The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126912691 12691269 1 I 20160627 20160818 20160826 20160826 EXP DE-MYLANLABS-2016M1035649 MYLAN 0.00 Y 0.00000 20160826 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126912691 12691269 1 PS SERTRALINE SERTRALINE HYDROCHLORIDE 1 Transplacental UNK (100 [MG/D (50 MG) ]/ SINCE 13.05.2016: 100 MG SERTRALINE) 78626
126912691 12691269 2 SS DIAZEPAM. DIAZEPAM 1 Transplacental UNK (8 [MG/D (-6 MG/D) ]/ FROM 28.04. UNTIL 26.05. 2016: 8 MG/D; WEEK 37+2 UNTIL DELIVERY3X2 MG/D) 0
126912691 12691269 3 C FEMIBION /01597501/ CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSFERROUS SUCCINATEMAGNESIUM HYDROXIDE 1 Transplacental UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126912691 12691269 1 Depression
126912691 12691269 2 Depression
126912691 12691269 3 Prophylaxis of neural tube defect

Outcome of event

Event ID CASEID OUTC COD
126912691 12691269 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126912691 12691269 Atrial septal defect
126912691 12691269 Drug withdrawal syndrome neonatal
126912691 12691269 Foetal exposure during pregnancy
126912691 12691269 Respiratory disorder neonatal

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126912691 12691269 1 20151003 20160627 0
126912691 12691269 2 20151003 20160627 0
126912691 12691269 3 20151015 20160627 0